AT-035

N/A

Report date: 2025/06/11 11:01:50
NME

Base Information

Drug NameAT-035
Drug Alias Namesynthetic nociceptin/orphanin FQ receptor partial agonists (Astraea Therapeutics/LSUHSC)AT-039AT-090AT-403AT-035 +[6] 
ClassificationSmall molecules
Mechanisms of ActionNociceptin receptor agonists
TargetsNociceptin receptor
Therapy Area/IndicationsAnxiety DisordersDepressionPain +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstraea Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesAstraea Therapeutics LLCLouisiana State University Health Sciences Center
Inactive CompaniesN/A
Active IndicationsAnxiety DisordersDepressionPain +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A